Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q2 2023 Earnings

11AugExpected

Q3 2022

Q4 2022

Q1 2023

Q2 2023

-56.25

-37.56

-18.87

-0.18

Details

Expected EPS

-3.48

Actual EPS

-56.25

Surprise EPS

-52.77

Surprise Percent

+1,516.38%

Description

Spyre Therapeutics (SYRE) has reported earnings of -56.25 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.